Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH
April 07 2011 - 4:11PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Inspire Pharmaceuticals, Inc. (“Inspire” or the
“Company”) (NasdaqGS: ISPH) for potential breaches of fiduciary
duties in connection with their conduct related to the sale of the
Company to Merck & Co.., Inc. (NYSE: MRK) for approximately
$430 million in cash. The proposed transaction offers Inspire
shareholders $5 per share in cash in exchange for each Inspire
share they hold. According to Yahoo! Finance, at least one
financial analyst values Inspire at $10 a share.
Request more information now by clicking here:
www.faruqilaw.com/ISPH.
Whether the Inspire’s Board of Directors breached their
fiduciary duties to Inspire’s stockholders by failing to conduct an
adequate and fair sales process to sell the Company prior to
agreeing to this proposed transaction, whether the proposed
transaction undervalues Inspire’s shares and by how much this
proposed transaction undervalues the Company to the detriment of
Inspire shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Inspire and wish to obtain additional
information, please visit us at www.faruqilaw.com/ISPH or contact
Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Inspire Pharmaceuticals, Inc. (MM) (NASDAQ:ISPH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Inspire Pharmaceuticals, Inc. (MM) (NASDAQ:ISPH)
Historical Stock Chart
From Dec 2023 to Dec 2024
